Clinical Trial Update: Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating semaglutide for diabetic kidney disease in people with Type 1 diabetes; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Type 1 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University of Washington | Conditions: Diabetic Kidney Disease, Type 1 Diabetes | Phase 2 | Status: RECRUITING